BioStem Technologies, Inc.
BSEM
$4.20
-$0.39-8.50%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | 215.82% | 216.48% |
| Total Depreciation and Amortization | -- | -- | -- | 27.19% | 11.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | 867.19% | 641.45% |
| Total Other Non-Cash Items | -- | -- | -- | -52.79% | -14.02% |
| Change in Net Operating Assets | -- | -- | -- | -1,941.25% | -3,701.58% |
| Cash from Operations | -- | -- | -- | 693.43% | 691.77% |
| Capital Expenditure | -- | -- | -- | -99.73% | -97.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 53.52% | 53.52% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -1,310.36% | -1,310.36% |
| Cash from Investing | -- | -- | -- | -451.62% | -450.52% |
| Total Debt Issued | -- | -- | -- | -97.37% | -97.37% |
| Total Debt Repaid | -- | -- | -- | -38.71% | -34.39% |
| Issuance of Common Stock | -- | -- | -- | 414.06% | 414.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -40.89% | -38.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | 1,656.85% | 1,656.85% |